Ryan D. Lake
Overview
Ryan D. Lake received an average of $2M in total compensation, including $346K in salary, at Recro Pharma from 2019 to 2022. Ryan Lake also received an average of $579K at Baudax Bio between 2019 and 2020.
Source: SEC filings on April 6, 2023, April 1, 2022, March 11, 2021, and March 25, 2021.
Related executives
We found nine more executives who work or worked at Recro Pharma and Baudax Bio.
J Enloe
Recro Pharma
Chief Executive Officer
Gerri Henwood
Baudax Bio
Chief Executive Officer
Richard Casten
Baudax Bio
Chief Financial Officer
Michael Celano
Recro Pharma
Chief Operating Officer
Ryan Lake
Recro Pharma
Chief Financial Officer
Stewart McCallum
Recro Pharma
Chief Medical Officer
Fred Graff
Recro Pharma
Chief Commercial Officer
Randall Mack
Recro Pharma
Senior Vice President, Development
News
Recro Pharma CEO J Enloe's 2022 pay jumps 107% to $2.3M
April 6, 2023
Recro Pharma CFO Ryan Lake's 2021 pay jumps 622% to $2.3M
April 1, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020